Eligibility Criteria GLP-1 medications, including semaglutide and tirzepatide, are typically prescribed for adults with a BMI of 30 or higher, or 27+ with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol
"How may GIP enhance the therapeutic efficacy of GLP-1?" Trends in Endocrinology & Metabolism , 31(6), 410-421
Categorical variables were reported using frequencies and percentages and analyzed using chi-squared tests where appropriate
If you have established cardiovascular disease or high risk, the SELECT trial data suggests staying on semaglutide provides ongoing protection
Gallbladder Concerns: Wegovy can increase the risk of gallstones
In 1993, Sikiric and colleagues in Zagreb isolated a cytoprotective protein from human gastric juice, called Body Protection Compound (BPC), whose fragment 157 (15 amino acids) reproduces most of its regenerative activity